YouthBio Therapeutics Exits Stealth Mode

The longevity company develops gene therapies aimed at rejuvenation via partial reprogramming by Yamanaka factors PRESS RELEASE — SEATTLE/PRNewswire/ — YouthBio Therapeutics, a longevity biotechnology company, has announced this week its emergence out of stealth mode. YouthBio focuses on developing gene therapies aimed at epigenetic rejuvenation, particularly with the help of partial reprogramming by Yamanaka factors. The company was …

YouthBio Therapeutics Exits Stealth Mode Read More »